Caribou Biosciences Aims For $255 Million IPO
Andrew Brookes/Cultura via Getty Images
Quick Take
Caribou Biosciences (CRBU) has filed to raise $255 million in an IPO of its common stock, according to an S-1/A registration statement.
The firm is a clinical-stage biopharma developing a novel CRISPR-based…
